Figure 9.
TIGIT and response of immunotherapy. (A) Prediction of immunotherapy in CTLA4 negative PD1 positive patients with high/low TIGIT expression. (B) Prediction of immunotherapy in CTLA4 positive PD1 negative patients with high/low TIGIT expression. (C) Prediction of immunotherapy in CTLA4 positive PD1 positive patients with high/low TIGIT expression. (D) Prediction of response to anti-PD1 or anti-CTLA4 immunotherapy by submap in KIRC patients with high/low TIGIT expression.
